Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Qatar has been on the rise in recent years, driven by a growing awareness of the importance of preventative healthcare measures and an increasing focus on immunization programs by the government.
Customer preferences: Qatar has a relatively young population, with a high proportion of expatriates, which has led to a diverse range of vaccination needs. The government has implemented a national immunization program that covers a range of diseases, including measles, mumps, rubella, and hepatitis B. Additionally, there is a growing demand for travel vaccines, particularly among expatriates who travel frequently for work or leisure.
Trends in the market: The vaccines market in Qatar is expected to grow steadily over the coming years, driven by an increasing focus on preventative healthcare and the government's continued investment in immunization programs. In particular, there is a growing demand for new and innovative vaccines, including those that target emerging diseases and illnesses. Additionally, there is an increasing interest in personalized vaccines that can be tailored to individual patients' needs.
Local special circumstances: Qatar is a wealthy country with a high standard of living, which has led to a strong demand for high-quality healthcare services. The government has invested heavily in healthcare infrastructure, including hospitals, clinics, and research facilities, which has helped to drive the growth of the vaccines market. Additionally, Qatar has a relatively small population, which has made it easier for the government to implement national immunization programs and ensure that all citizens and residents have access to vaccines.
Underlying macroeconomic factors: Qatar has a strong and stable economy, driven by its vast oil and gas reserves. The government has used its wealth to invest in a range of sectors, including healthcare, which has helped to drive the growth of the vaccines market. Additionally, Qatar has a strategic location in the Middle East, which has made it an attractive destination for international healthcare providers and pharmaceutical companies. Overall, the vaccines market in Qatar is expected to continue to grow in the coming years, driven by a combination of strong customer demand, government investment, and favorable macroeconomic conditions.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
